Twitter Beğeni Hilesi

Our NaCl story would have not been possible without the tremendous support of the Cancer Research Institute STAR program.

Researchers including 2022 William B. Coley Award recipient Dr. Judy Lieberman Boston Children's indicate that tumors edit multiple genes to avoid recognition by the immune system. Discover how this could provide a map for designing better immunotherapies: on.bchil.org/4cFWKSW

Make your donation to the Cancer Research Institute go twice, or even three times as far, with your employer's matching gift program! Learn how you can magnify your impact on cancer immunotherapy research today: bit.ly/45p0bu7 #EmployerMatch #CancerResearch

"Mucinomics is the study of a class of proteins called mucins. We try to leverage changes in mucins for improved diagnostic or therapeutic strategies," CRI Lloyd J. Old STAR Dr. Stacy Malaker Stacy Malaker of Yale University Yale Chemistry describes. Read more: bit.ly/4cIkUft

Your attendance at #CICON24 puts you at the forefront of cutting-edge advancements in cancer immunotherapy. Register now for the Eighth International Cancer Immunotherapy Conference: Translating Science into Survival, held on September 8-11, 2024: bit.ly/49Bceq8

Ho Lab 9-year celebration. We have a great journey and a super lovely team. Thanks for having a special guest joining us, my first master student Laura. Thanks for the sustained support from Ludwig Cancer & Cancer Research Institute

Did you know? The Cancer Research Institute is ranked among the top 5% of all U.S. rated charities. Give with confidence, and make an impact by donating today to fund lifesaving cancer immunotherapy research: bit.ly/3qDkt47 #CancerResearch #Immunotherapy

Discover key innovations, and understand ongoing challenges in multiple myeloma treatment, according to City of Hope's Dr. Amrita Krishnan, in an interview with Targeted Oncology: bit.ly/3YS9cvl #MultipleMyeloma #CancerResearch #Immunotherapy

Did you know? September is Prostate Cancer Awareness Month. Make a gift today to advance groundbreaking cancer immunotherapy research, and give hope to prostate cancer patients everywhere: bit.ly/3qDkt47 #ProstateCancer #ProstateCancerAwarenessMonth #Immunotherapy

I'm excited to share that, in just a week, I'll be presenting our work on hematopoietic aging and cancer from the lab of Miriam Merad, MD, PhD Icahn School of Medicine at Mount Sinai The Tisch Cancer Institute Lipschultz Precision Immunology Institute at #CICON24 Cancer Research Institute. Looking forward to seeing everyone there!

Led by CRI Scientific Advisory Council member Dr. Sharma MD Anderson Cancer Center, findings from the AMADEUS clinical trial shed light on how biomarkers can predict patients' responses to immune checkpoint inhibitor treatments including nivolumab and ipilimumab: bit.ly/4e5izwm

Spend a minute with CRI Postdoctoral Fellow Dr. Joseph Muldoon of UC San Francisco, as he discusses how machine learning enables researchers to conduct more thorough experimentation. Watch now, or tune into more Immunotherapy Minutes on our website: bit.ly/45yRoXy #CancerResearch

Are you coming CICON24 in Washington DC next week? Come talk to two of my terrific students Stanislav Dergun and Yi-Hao. I will also present our new works in T cell exhaustion and CD19 human CAR T. Cancer Research Institute 🔥

Globally, young people under 20 receive a cancer diagnosis roughly every 2 minutes, impacting roughly 300,000 children and adolescents each year. During #ChildhoodCancerAwarenessMonth, make an impact by giving to accelerate cancer immunotherapy research: bit.ly/3qDkt47

According to new findings from Michigan Medicine researchers, many women diagnosed with early-stage breast cancer did not receive genetic testing, despite meeting the criteria for it. Learn more with Healio: bit.ly/3AHsRnX #BreastCancer #CancerResearch #bcsm

“My experience with immunotherapy was truly a miracle that saved my life and allowed me to bring a new life into this world. For that, I am forever grateful," emphasizes CRI ImmunoAdvocate Sonia. Discover her immunotherapy success story: bit.ly/3ThRVbA #Immunotherapy

During #BloodCancerAwarenessMonth, discover how CRI CLIP Investigators Dr. Marco Ruella U of Penn and Dr. Matteo Maria Bellone Università Vita-Salute San Raffaele are working to improve immunotherapy outcomes for blood cancer patients: bit.ly/4cVi0nM #Leukemia #Lymphoma #MultipleMyeloma

Science Magazine Matthew D. Park, Ph.D. Miriam Merad, MD, PhD Attendees of #CICON24 can hear more about the mechanisms linking immune aging to cancer in Matthew D. Park, Ph.D.'s presentation in Session 5:  The Role of Myeloid Cells in the Anti-tumor Response 🗓️Monday Sept 9, 11:10 AM - 1:25 PM

A new study by Yale Cancer Center researchers, published in NCBI's Pigment Cell & Melanoma Research, highlights "unmet needs for patients with melanoma who progress or relapse after immunotherapy treatment." Discover: bit.ly/47i8FFd #melnm #Melanoma #Immunotherapy

#CICON24 is an unparalleled event in cancer immunology, bringing together global experts to explore groundbreaking research and innovations that are reshaping the future of cancer treatment! Join us there, from September 8-11, 2024: bit.ly/4cXmgD2 ENCI Cancer Immunotherapy